|
Volumn 57, Issue 2, 2011, Pages
|
Metabolic actions could confound advantageous effects of combined angiotensin II receptor and neprilysin inhibition
|
Author keywords
[No Author keywords available]
|
Indexed keywords
ANGIOTENSIN RECEPTOR;
MEMBRANE METALLOENDOPEPTIDASE;
NATRIURETIC PEPTIDE RECEPTOR A;
ADIPOSE TISSUE;
BLOOD PRESSURE;
ENZYME INHIBITION;
HEART LEFT VENTRICLE EJECTION FRACTION;
HYPERTENSION;
LETTER;
LIPID METABOLISM;
LIPID OXIDATION;
LIPOLYSIS;
METABOLISM;
PRIORITY JOURNAL;
ADIPOCYTES;
ADRENERGIC BETA-AGONISTS;
AMINOBUTYRIC ACIDS;
ANGIOTENSIN RECEPTOR ANTAGONISTS;
ATRIAL NATRIURETIC FACTOR;
CELLS, CULTURED;
DOSE-RESPONSE RELATIONSHIP, DRUG;
FEMALE;
HEART FAILURE;
HUMANS;
ISOPROTERENOL;
LIPOLYSIS;
MALE;
MIDDLE AGED;
NEPRILYSIN;
RECEPTORS, ANGIOTENSIN;
TETRAZOLES;
VENTRICULAR DYSFUNCTION, LEFT;
|
EID: 79551471674
PISSN: 0194911X
EISSN: None
Source Type: Journal
DOI: 10.1161/HYPERTENSIONAHA.110.165159 Document Type: Letter |
Times cited : (28)
|
References (5)
|